Skip NavigationSkip to Content

Impaired Control of Epstein Barr Virus Infection in B-Cell Expansion with NF-kappa B and T-Cell Anergy Disease

  1. Author:
    Arjunaraja, Swadhinya
    Angelus, Pam
    Su, Helen C.
    Snow, Andrew L.
  2. Author Address

    Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, Bethesda, MD 20814 USA.NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.Leidos Biomed Res Inc, Natl Canc Inst Frederick, Clin Res Directorate, Clin Monitoring Res Program, Frederick, MD USA.
    1. Year: 2018
    2. Date: Feb 8
  1. Journal: FRONTIERS IN IMMUNOLOGY
  2. FRONTIERS MEDIA SA,
    1. 9
  3. Type of Article: Review
  4. Article Number: 198
  5. ISSN: 1664-3224
  1. Abstract:

    B-cell expansion with NF-kappa B and T-cell anergy (BENTA) disease is a B-cell-specific lymphoproliferative disorder caused by germline gain-of-function mutations in CARD11 These mutations force the CARD11 scaffold into an open conformation capable of stimulating constitutive NF-kappa B activation in lymphocytes, without requiring antigen receptor engagement. Many BENTA patients also suffer from recurrent infections, with 7 out of 16 patients exhibiting chronic, low-grade Epstein Barr virus (EBV) viremia. In this mini-review, we discuss EBV infection in the pathogenesis and clinical management of BENTA disease, and speculate on mechanisms that could explain inadequate control of viral infection in BENTA patients.

    See More

External Sources

  1. DOI: 10.3389/fimmu.2018.00198
  2. PMID: 29472930
  3. WOS: 000424472200001

Library Notes

  1. Fiscal Year: FY2017-2018
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel